Physician profile
Karin Denevi
NPI 1316916224
$651.25
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $74.44 · 2021: $245 · 2022: $22.44 · 2023: $9.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $138.38 | 2019-2021 | |
| Abbvie INC. | $111.91 | 2019-2022 | |
| Novo Nordisk INC | $83.15 | 2019-2021 | |
| Therapeuticsmd, INC. | $74.57 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $53.29 | 2019 | |
| Nestle Healthcare Nutrition INC. | $25.90 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $24.30 | 2021 | |
| Bausch Health US, LLC | $24.26 | 2019 | |
| Ibsa Pharma INC. | $18.40 | 2019 | |
| Merck Sharp & Dohme LLC | $16.53 | 2019 | |
| Allergan, INC. | $16.08 | 2019 | |
| Lupin INC. | $16.00 | 2020 | |
| Glaxosmithkline, LLC. | $15.23 | 2021 | |
| Ascend Therapeutics US, LLC | $11.90 | 2021 | |
| Exeltis, USA INC. | $11.62 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $9.73 | 2023 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karin Denevi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.